Mary Greeley Cancer Case Conference
A multi-disciplinary clinical activity which serves to maintain, develop, or increase the knowledge, skills, professional performance, and relationships that a physician uses to provide services for patients, the public, or the profession.
Limited to MGMC-approved providers, referring physicians, and other health care providers who practice and/or refer patients for care at Mary Greeley Medical Center.
Following the conference, participants should have an enhanced understanding about diagnostic procedures and treatment planning for patients with the following types of cancer: Invasive Ductal Carcinoma, Ductal Carcinoma In Situ, Superficial Spreading Malignant Melanoma, Adenocarcinoma, Diffuse Large B-Cell Lymphoma, High-Grade B-Cell Lymphoma, Hodgkin Lymphoma.
Trisha Andersen, DO
Pathologist, McFarland Clinic, Ames, IA
None of the MGMC CME Committee members, who planned this CME activity, have any financial relationships to disclose relating to the content of the selected cases. Trisha Andersen, DO, Jamie Weydert, MD, and Christopher Johnson, MD, facilitators of Cancer Case Conference, disclose they have no financial relationships with a commercial entity producing healthcare-related products and/or services.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.0 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
No ineligible company provided financial support for this continuing education activity.
Everyone in a position to control the content of this educational activity will disclose to the CME provider and attendees all relevant financial relationships with any commercial interest. The speaker(s) will disclose if any pharmaceuticals, medical procedures, and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The determination of educational content and the selection of speakers is the responsibility of the activity director. Firms providing financial support did not have input in these areas.
The information provided in this activity is for continuing education purposes only. It is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
- 1.00 AOA Category 1A